The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Drapkina O.M.

Pervyĭ Moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova, Klinika propedevtiki vnutrennikh bolezneĭ, gastroénterologii i gepatologii

Shepel R.N.

National Research Center for Preventive Medicine, Moscow, Russia, 101990

Yakovenko E.P.

The Russian National Research Medical University named after N.I. Pirogov, Moscow, Russia

Zyatenkova E.V.

National Research Center for Preventive Medicine, Moscow, Russia

Non-invasive methods for detection of progressive fibrosis in patients with nonalcoholic fat liver disease

Authors:

Drapkina O.M., Shepel R.N., Yakovenko E.P., Zyatenkova E.V.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2019;22(2): 82‑88

DOI: 10.17116/profmed20192202182

Read: 25814 times

Download PDF (RU)
Contact the author
Table of contents

NON-INVASIVE METHODS FOR DETECTION OF PROGRESSIVE FIBROSIS IN PATIENTS WITH NONALCOHOLIC FAT LIVER DISEASE
NON-INVASIVE METHODS FOR DETECTION OF PROGRESSIVE FIBROSIS IN PATIENTS WITH NONALCOHOLIC FAT LIVER DISEASE

To cite this article:

Drapkina OM, Shepel RN, Yakovenko EP, Zyatenkova EV. Non-invasive methods for detection of progressive fibrosis in patients with nonalcoholic fat liver disease. Russian Journal of Preventive Medicine. 2019;22(2):82‑88. (In Russ.)
https://doi.org/10.17116/profmed20192202182

Подписка 2026 Профилактическая медицина (Russian Journal of Preventive Medicine)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

The review presents the main non-invasive methods for detecting progressive fibrosis in patients with non-alcoholic fatty liver disease (NAFLD), which are used to determine the degree of expression of necroinflammatory changes and the stage of liver fibrosis in this pathology.

Keywords:

NAFLD
BARD
NFS
HAIR
FIB-4
BAAT
NICE
FLI
APRI
CDS
ELF
Nash Test

Authors:

Drapkina O.M.

Pervyĭ Moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova, Klinika propedevtiki vnutrennikh bolezneĭ, gastroénterologii i gepatologii

Shepel R.N.

National Research Center for Preventive Medicine, Moscow, Russia, 101990

Yakovenko E.P.

The Russian National Research Medical University named after N.I. Pirogov, Moscow, Russia

Zyatenkova E.V.

National Research Center for Preventive Medicine, Moscow, Russia

Close metadata

References:

  1. Lazebnik LB, Radchenko VG, Golovanova EV, Zvenigorodskaya LA, Konev YuV, Seliverstov PV, Sitkin SI, Tkachenko EI, Avaluyeva EB, Aylamazyan EK, Vlasov NN, Grinevich VB, Korniyenko EA, Novikova VP, Khoroshinina LP, Zhestkova NV, Oreshko LS, Dudanova OP, Dobritsa VP, Tur’yeva LV, Tirikova OV, Kozlova NM, Yeliseyev SM, Gumerov RR, Ventsak EV, Aleshina EI, Gurova MM, Goryacheva LG. Nonalcoholic fatty liver disease: clinic, diagnostics, treatment (recommendations for therapists, 2nd version). Terapiya. 2017;3(13):6-23. (In Russ.).
  2. Carr RM, Oranu A, Khungar V. Nonalcoholic fatty liver disease: pathophysiology and management. Gastroenterol Clin North Am. 2016;45:639-652. https://doi.org/10.1016/j.gtc.2016.07.003
  3. Drapkina OM, Ivashkin VT. Epidemiological features of non-alcoholic fatty liver disease in Russia (results of an open multicenter prospective study-observation direg l 01903). Rossiyskiy zhurnal gastroehnterologii, gepatologii, koloproktologii. 2014;24(4):32-38. (In Russ.).
  4. Ivashkin VT, Drapkina OM, Mayev IV, Trukhmanov AS, Blinov DV, Pal’gova LK, Tsukanov VV, Ushakova TI. Prevalence of non-alcoholic fatty liver disease in patients of out-patient clinic practice in the Russian Federation: results of the DIREG study 2. Rossijskiy zhurnal gastroehnterologii, gepatologii, koloproktologii. 2015;6:31-41. (In Russ.).
  5. Schwimmer JB, Behling C, et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology. 2005;42:641-649. https://doi.org/10.1002/hep.20842
  6. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980;55:434-438.
  7. Adams L. Transient elastography in nonalcoholic fatty liver disease: making sense of echoes. Hepatology. 2010;51:370-372. https://doi.org/10.1002/hep.23422
  8. Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328-357. https://doi.org/10.1002/hep.29367
  9. Castera L, Negre I, et al. Pain experienced during percutaneous liver biopsy. Hepatology. 1999;30:1529-1530. https://doi.org/10.1002/hep.510300624
  10. Piccinino F, Sagnelli E, et al. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol. 1986;2:165-173.
  11. Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology. 2003;38:1449-1457. https://doi.org/10.1016/j.hep.2003.09.022
  12. Colloredo G, Guido M, et al. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol. 2003;39:239-244. https://doi.org/10.1016/S1590-8658(11)60589-6
  13. Regev A, Berho M, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol. 2002;97:2614-2618. https://doi.org/10.1111/j.1572-0241.2002.06038.x
  14. Maharaj B, Maharaj RJ, Leary WP, et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet. 1986;1:523-525.
  15. Ratziu V, Giral P, et al. Liver fibrosis in overweight patients. Gastroenterology. 2000;118:1117-1123. https://doi.org/10.1016/S0016-5085(00)70364-7
  16. Ulitsky A, Ananthakrishnan AN, et al. A noninvasive clinical scoring model predicts risk of nonalcoholic steatohepatitis in morbidly obese patients. Obes Surg. 2010;20:685-691. https://doi.org/10.1007/s11695-010-0118-y
  17. Alberti KGMM, Zimmet PZ, Shaw JE. The metabolic syndrome — a new worldwide definition from the International Diabetes Federation Consensus. Lancet. 2005;366:1059-1062. https://doi.org/10.1016/S0140-6736(05)67402-8
  18. Bedogni G, Bellentani S, et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33. https://doi.org/10.1186/1471-230X-6-33
  19. Poynard T, Ratziu V, et al. Diagnostic value of biochemical markers (NashTest) for the prediction of nonalcoholo steatohepatitis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol. 2006;6:34. https://doi.org/10.1186/1471-230X-6-34
  20. McPherson S, Stewart SF, Henderson E, et al. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut. 2010;59:1265-1269. https://doi.org/10.1136/gut.2010.216077
  21. Shah AG, Lydecker A, Murray K. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009;7:1104-1112. https://doi.org/10.1016/j.cgh.2009.05.033
  22. Harrison SA, Oliver D, Arnold HL. Development and validation of a simple NALFD clinical scoring system for identifying patient without advanced diseases. Gut. 2008;57:1441-1447. https://doi.org/10.1136/gut.2007.146019
  23. L-ALEH Clinical Practice Guidelines: Noninvasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63(1):237-264. https://doi.org/10.1016/j.jhep.2015.04.006
  24. Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45:846-854. https://doi.org/10.1002/hep.21496
  25. Gambino R, Cassader M, Pagano G. Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med. 2011;43(8):617-649. https://doi.org/10.2147/CLEP.S144368
  26. Chalasani N, Younossi Z, et al. The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2012;142:1592-1609. https://doi.org/10.1002/hep.25762
  27. Vallet-Pichard A, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology. 2007;46(1):32-36. https://doi.org/10.1002/hep.21669
  28. Anty R, Iannelli A, et al. A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients. Aliment Pharmacol Ther. 2010;32:1315-1322. https://doi.org/10.1111/j.1365-2036.2010.04480.x
  29. Ahmed M. Non-alcoholic fatty liver disease in 2015. World J Hepatol. 2015;7:1450-1459. https://doi.org/10.4254/wjh.v7.i11.1450
  30. Bonacini M, Hadi G, Govindarajan S, Lindsay KL. Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol. 1997;92(8):1302-1304.
  31. Hassan K, Bhalla V, El Regal ME, A-Kader HH. Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic. World J Gastroenterol. 2014;20(34):12082-12101. https://doi.org/10.3748/wjg.v20.i34.12082
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.